PLEX (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that entrap a therapeutic drug.
This self-assembled matrix forms a protected reservoir that enables controlled and continuous delivery of drugs over periods ranging from days to several months.
PLEX-based protected drug reservoirs enable prolonged delivery of sensitive drugs over periods ranging from days to several months.
The clinical application of our PLEX technology provides optimized continuous local drug delivery in the body over a prolonged time (week to months) in a single application, a rare combination of attributes.
VIDEO:
PLEX DRUG
DELIVERY PLATFORM
PLEX REVOLUTIONIZES LOCALIZED DRUG DELIVERY
OPTIMIZED THERAPEUTICS
Our studies show that our products are highly effective at the targeted site despite the drug dose delivered locally being small fraction of the traditional administrated systemic doses.
The use of a well-controlled, locally effective, dose minimizes potential side effects and aimed to improve overall patient outcomes.
LOCAL CONDITIONS NEED LOCAL SOLUTIONS
Our localized medication solution is essential in many treatment regimens where surgeons desire a single application to improve treatment outcomes, such as:
- Prevention of infections
- Post surgical pain
- Inflammation
- Cancer tumor resection
In organs with limited blood supply, our drug delivery technology overcomes systemic penetration challenges encountered in various locations in the body, including bone and brain.
THE BREADTH OF THE PLEX PLATFORM
(1) Clinical stage | (2) In-vivo POC | (3) In-vitro POC
STRONG INTELLECTUAL PROPERTY POSITIONING
- Platform
- Method of use
- Sophisticated "know how"
- 156 issued patents and 20 pending patent applications